Single-nucleotide Polymorphism of CD36 Locus and Obesity in European Adolescents (Q57605753)

Philippe Amouyel

8

0 references

Kurt Widhalm

6

Kurt Widhalm

0 references

Jean Dallongeville

11

Jean Dallongeville

0 references

Yannis Manios

7

Yannis Manios

0 references

Luis Moreno

9

Luis A. Moreno

0 references

Jonatan R Ruiz

4

Jonatan R. Ruiz

0 references

Szilvia Bokor

1

Szilvia Bokor

0 references

Vanessa Legry

2

Vanessa Legry

0 references

Dénes Molnar

10

Dènes Molnàr

0 references

author name string

Beatrice Mauro

CD36: implications in cardiovascular disease

5

0 references

publication date

5 November 2009

0 references

published in

Obesity

0 references

volume

18

0 references

issue

7

0 references

page(s)

1398-1403

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.412

A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.412

CD36-facilitated fatty acid uptake inhibits leptin production and signaling in adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.412

Pathophysiology of Human Genetic CD36 Deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.412

Physiological and pathological roles of a multi-ligand receptor CD36 in atherogenesis; insights from CD36-deficient patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.412

Expression of fatty-acid-handling proteins in human adipose tissue in relation to obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.412

Variants in the CD36 gene associate with the metabolic syndrome and high-density lipoprotein cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.412

Direct association of a promoter polymorphism in the CD36/FAT fatty acid transporter gene with Type 2 diabetes mellitus and insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.412

Genetic study of the CD36 gene in a French diabetic population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.412

Establishing a standard definition for child overweight and obesity worldwide: international survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.412

Design and implementation of the Healthy Lifestyle in Europe by Nutrition in Adolescence Cross-Sectional Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.412

Assessing, understanding and modifying nutritional status, eating habits and physical activity in European adolescents: the HELENA (Healthy Lifestyle in Europe by Nutrition in Adolescence) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.412

Quality assurance of ethical issues and regulatory aspects relating to good clinical practices in the HELENA Cross-Sectional Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.412

Harmonization process and reliability assessment of anthropometric measurements in a multicenter study in adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.412

Sampling and processing of fresh blood samples within a European multicenter nutritional study: evaluation of biomarker stability during transport and storage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.412

A new algorithm for haplotype-based association analysis: the Stochastic-EM algorithm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.412

Specific haplotypes of the P-selectin gene are associated with myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.412

A new JAVA interface implementation of THESIAS: testing haplotype effects in association studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.412

Genome wide association (GWA) study for early onset extreme obesity supports the role of fat mass and obesity associated gene (FTO) variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.412

Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.412

Molecular basis of human CD36 gene mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.412

MatInspector and beyond: promoter analysis based on transcription factor binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.412

Role of CD36 in membrane transport of long-chain fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.412

Metabolism of lipids in human white adipocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.412

Macrophage-secreted factors impair human adipogenesis: involvement of proinflammatory state in preadipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.412

Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.412

PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.412

Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.412

Hexarelin Signaling to PPARgamma in Metabolic Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.412

Muscle-specific overexpression of FAT/CD36 enhances fatty acid oxidation by contracting muscle, reduces plasma triglycerides and fatty acids, and increases plasma glucose and insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.412

Effects of obesity and weight loss on the expression of proteins involved in fatty acid metabolism in human adipose tissue

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.412

A common haplotype at the CD36 locus is associated with high free fatty acid levels and increased cardiovascular risk in Caucasians

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.412

CD36 polymorphism and its relationship with body mass index and coronary artery disease in a Korean population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.412

Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.412

CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.412

inferred from DOI database lookup

7 January 2021

based on heuristic

A promoter polymorphism in CD36 is associated with an atherogenic lipid profile in a French general population

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.412